Answers are grounded in this paper and cite their sources.
Chronic HIV-1 infection is characterized by persistent CD8⁺ T-cell exhaustion, which impedes effective viral control and serves as a major barrier to achieving complete immune reconstitution in people living with HIV (PLWH) receiving suppressive antiretroviral therapy (ART). While classic co-inhibitory receptors are central to this process, the functional plasticity of canonical co-stimulatory molecules in driving T-cell exhaustion remains underexplored. Here, we investigated the role of T cell-intrinsic CD86, a member of the B7 family traditionally recognized as a co-stimulatory ligand on antigen-presenting cells (APCs), in T-cell exhaustion during HIV-1 infection. Flow cytometry was performed to assess CD86 expression on CD8⁺ T cells and to characterize their phenotypic, functional, and intracellular signaling profiles. HIV-1-specific responses were evaluated following peptide pool stimulation, and cytokine stimulation assays in vitro were used to identify factors promoting CD86 upregulation. Bulk RNA sequencing (RNA-seq), qRT-PCR, and analysis of publicly available single-cell RNA-seq (scRNA-seq) datasets were employed to characterize transcriptional features and provide external validation. We identified a significantly elevated frequency of CD86⁺CD8⁺ T cells in treatment-naive PLWH, which strongly correlated with HIV-1 disease progression and persistent immune activation. Phenotypic and functional analyses, supplemented by scRNA-seq, revealed that these cells exhibited a profound exhaustion program, characterized by upregulation of co-inhibitory receptors, impaired effector function, and distinct transcriptional reprogramming. We identified IL-15 as a key driver of intrinsic CD86 upregulation, linking excessive proliferation-driven replicative stress with functional impairment during HIV-1 infection. Mechanistically, we demonstrated that T cell-intrinsic CD86 functioned as a non-canonical co-inhibitory receptor that drove exhaustion via reverse signaling, which suppressed the Akt-mTOR and NF-κB (p50) signaling pathways. Furthermore, high baseline frequencies of CD86⁺CD8⁺ T cells showed potential predictive value for poor immune recovery after ART. Our findings established CD86 as a novel regulator of CD8⁺ T-cell exhaustion and highlighted its potential as a biomarker for predicting immune reconstitution in PLWH. These insights offer a new perspective on the functional plasticity of co-inhibitory molecules and identify CD86 as a potential target for therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: